News
Media
Conferences
Publication
Job Board
CME/CE
Partners
Editorial
Resources
Subscribe

Spotlight -

Long-Acting Injectable Therapy in the Management of Adult Patients with Schizophrenia|

Major Depressive Disorder

Gina Jamal, MD

Articles by Gina Jamal, MD

Ktsdesign/AdobeStock

The Impact of Selective Serotonin Reuptake Inhibitors on Bleeding Risk: A Comprehensive Review

ByParas Gupta, MBE,Sarah Hakam, BS,Arsalan Nisar, MS,Inna D'Empaire, MD,Gina Jamal, MD,Reza Safavi, MD

February 3rd 2025

What patients are at risk when taking SSRIs?

Latest Updated Articles

The Impact of Selective Serotonin Reuptake Inhibitors on Bleeding Risk: A Comprehensive Review
Published: February 3rd 2025 | Updated:

Trending on Psychiatric Times

FDA Accepts NDA for Priority Review: Centanafadine for Treatment of ADHD

Treating Inflammation to Relieve Depression, Anhedonia

Type C Meeting With FDA Completed for Zervimesine in Dementia With Lewy Bodies

International Holocaust Remembrance Day and Our Long Road Trip

A New and Improved DSM? The American Psychiatric Association Shares Strategy and Roadmap